TARGETING METHYLGLYOXAL AND PPAR GAMMA TO ALLEVIATE NEUROPATHIC PAIN ASSOCIATED WITH TYPE 2 DIABETES

TARGETING METHYLGLYOXAL AND PPAR GAMMA TO ALLEVIATE NEUROPATHIC PAIN ASSOCIATED WITH TYPE 2 DIABETES

Neuropathic pain affects up to 50% of the 29 million diabetic patients in the United States. Neuropathic pain in diabetes manifests as a disease of the peripheral and central nervous systems. The prevalence of type 2 diabetes is far greater than type 1 (90%), yet the overwhelming focus on type 1 mod...

Full description

Bibliographic Details
Main Author: Griggs, Ryan B.
Format: Others
Published: UKnowledge 2015
Subjects:
painful type 2 diabetes
pioglitazone
chronic neuropathic pain
methylglyoxal
TRPA1
PPAR gamma
Behavioral Neurobiology
Medical Neurobiology
Molecular and Cellular Neuroscience
Neurosciences
Online Access:https://uknowledge.uky.edu/physiology_etds/24
https://uknowledge.uky.edu/cgi/viewcontent.cgi?article=1024&context=physiology_etds

Internet

https://uknowledge.uky.edu/physiology_etds/24
https://uknowledge.uky.edu/cgi/viewcontent.cgi?article=1024&context=physiology_etds

Similar Items